Detect diabetic neuropathy before it becomes irreversible.
SudoCheck assesses small nerve fiber sudomotor function — the earliest measurable marker of diabetic neuropathy. Catch it before clinical symptoms, before foot complications, and before irreversible nerve damage occurs.
Why diabetic neuropathy testing matters.
Diabetic neuropathy affects up to 50% of patients with diabetes, yet it is frequently underdiagnosed until complications appear. The American Diabetes Association recommends autonomic nervous system testing as a standard of care for all diabetic patients. VitalScan ANS+ makes this testing automated, reproducible, and billable — fitting into a single 15-minute in-office visit.
Built for the specialties that manage this condition.
Billable under standard CPT codes.
95921–95924Autonomic nervous system function testing93922–93971Vascular studies including arterial Doppler and ABIWhat it adds to your practice.
Estimated monthly revenue
3 tests/day × ~$200 avg = $12,000/month
Based on 3 tests per day, 20 working days per month. Actual reimbursement varies by payer and region.
Non-invasive, automated, and reproducible. The entire assessment fits into a single patient visit — no special prep, no dedicated technician required.
Ready to add diabetic neuropathy testing to your practice?
Get a personalized ROI analysis with clinical workflow, CPT billing guidance, and financing options — including Section 179 and grant pathways.